Ocular Therapeutix beats by $0.16, revenue in-line

|About: Ocular Therapeutix (OCUL)|By:, SA News Editor

Ocular Therapeutix (NASDAQ:OCUL): Q2 EPS of -$2.10 beats by $0.16.

Revenue of $0.1M in-line.